| Name | Title | Contact Details |
|---|
Crowd Factory is one of the leading providers in Software and Internet. It is based in San Francisco, CA. To find more information about Crowd Factory, please visit www.crowdfactory.com.
Rekos Technology and Design is a Groton, MA-based company in the Software and Internet sector.
Second Baptist Church is a religious institution located in Houston, TX with 6 locations across the city and programs for all ages and stages. They are a community of believers from all different walks of life, united together by their hope in Jesus Ch...
Proclivity enables online retailers to execute revenue-generating, direct marketing campaigns based on their customer's individual valuations and forecasted willingness to buy. Proclivity accomplishes this by gathering all of a retailer's consumer data into its unique Consumer Behavior Bank, scoring each consumer and generating individual valuations by product. Marketers can use this information to easily create and launch highly targeted campaigns through the consumer's preferred channels, with success metrics in excess of 20% revenue lift and 300% ROI. The Proclivity platform also helps retailers retain existing customers and acquire new ones. For more information, visit www.ProclivitySystems.com.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.